This document discusses long-term oxygen therapy (LTOT) and home oxygen therapy. It provides an overview of the terminology, scientific background, equipment, indications, and practical considerations of LTOT. It also includes two case studies examining whether a patient should start or continue LTOT. The document summarizes the effects of LTOT including improved survival, decreased hospitalizations, and improved quality of life for COPD patients. It addresses portable oxygen therapy and the prevalence of home oxygen therapy in different countries.
This document discusses long-term oxygen therapy (LTOT) and home oxygen therapy. It provides an overview of the terminology, scientific background, equipment, indications, and practical considerations of LTOT. It also includes two case studies examining whether a patient should start or continue LTOT. The document summarizes the effects of LTOT including improved survival, decreased hospitalizations, and improved quality of life for COPD patients. It addresses portable oxygen therapy and the prevalence of home oxygen therapy in different countries.
1) Home oxygen therapy (HOT) improves survival in patients with hypoxemia, though adherence to guidelines and follow-up is only about 50% in many countries.
2) Continuous oxygen therapy (COT) given for over 15 hours daily increases survival by 2-4 years in COPD patients with low oxygen levels. Portable oxygen allows more activity but devices are still heavy.
3) International guidelines recommend COT for patients with oxygen levels below 7.3 kPa, but adherence varies, from 35-81% of eligible patients receiving treatment across different countries. Follow-up after starting COT is also inconsistent.
This document discusses home oxygen treatment. It provides an overview of the scientific evidence for indications and effects of oxygen therapy. It also reviews prevalence, devices, side effects, and practical considerations for home oxygen treatment in Denmark. A case study is presented on whether a 65-year-old woman with COPD exacerbation should start chronic oxygen therapy. Guidelines for initiating oxygen are outlined. Survival rates on oxygen are compared between countries.
Chemotherapy is the main treatment for disseminated cancers. It involves using multiple drugs in cycles to target rapidly dividing cancer cells. Common drugs include alkylating agents, antimetabolites, microtubule inhibitors, and monoclonal antibodies. Combination chemotherapy aims to maximize responses while avoiding overlapping toxicities. Doses are based on body surface area and adjusted for individual factors. Treatment intervals allow time for normal tissues to recover between cycles. Toxicities include myelosuppression, nausea/vomiting, and alopecia. Response is evaluated based on tumor shrinkage or progression.
How Smart Business Intelligence Yields Rapid Association GrowthThomas B. McClintock
After taking on the marketing challenges of ten participating organizations at MMCC ‘14, the Marketing Council’s “Doctor Is In” team has continued investigating more solutions since and has found success lies in interpreting and acting upon market data. Marketing connects people to solutions, and association marketers are uniquely positioned to make those connections across an entire vertical. But what happens when your entire vertical shifts, like healthcare or metal treatment? How can associations use Business Intelligence and Data Analytics to keep up with emerging trends and continue as a trusted resource, advisor or curator for key stakeholders? Join key association leaders who outpaced their competitors for an “Ask the Gurus” session to examine multiple best-in-class examples and distill strategies that can be scaled and applied to a wide variety of associations seeking rapid growth.
1. Yes, the patient meets the criteria for home oxygen therapy with a PO2 <7.3 kPa at rest.
2. Portable oxygen for mobile hypoxemic patients is intended to:
- Increase hours on oxygen
- Increase daily activity
3. Studies have found no effect of adding ambulatory oxygen to pulmonary rehabilitation programs. Ambulatory oxygen alone does not improve exercise tolerance long-term.
This document discusses home oxygen therapy (HOT) in various countries. It provides an overview of the types of HOT, including continuous oxygen therapy (COT), short-term oxygen therapy (STOT), and nocturnal oxygen therapy (NOT). Clinical trials show that COT improves survival in COPD patients with low oxygen levels. Guidelines for COT recommend a minimum daily usage of 15 hours and follow-up every 3-6 months. Adherence to HOT varies significantly between countries, from 60% in Denmark to rates as low as 27% in some studies. Portable oxygen improves mobility and activity levels but is underutilized in many patients.
This document summarizes findings from the Danish Oxygen Register regarding long-term oxygen therapy (LTOT) in Denmark from 1994-2000. Some key findings include:
- The prevalence and incidence of COPD patients on LTOT increased and reached a plateau around 25 and 40 per 100,000 respectively.
- There was an increase in the proportion of cancer patients, older patients, and those using mobile oxygen units starting LTOT. The percentage treated over 15 hours daily and after hospital admission also rose.
- Around 20-25% of COPD patients on LTOT were still smoking despite the therapy.
- Survival rates improved over the period, however remained lower than other countries due to higher 6-
This document discusses long-term oxygen therapy (LTOT). It provides an overview of the terminology, scientific background, equipment, indications, and quality of LTOT treatment. Specifically:
1) It defines various types of home oxygen therapy including LTOT, short-term oxygen therapy (STOT), ambulatory oxygen therapy, and oxygen used for palliation of attacks of dyspnea.
2) It reviews studies showing the effects of LTOT on survival, health outcomes, and hospitalizations for COPD patients. LTOT is shown to increase survival by 2-4 years and decrease hospitalizations by 25% for qualifying patients.
3) It discusses considerations for starting, controlling, and ensuring quality of LT
The document discusses the impact of Denmark's national oxygen register on adherence to guidelines for long-term oxygen therapy (LTOT) in COPD patients. Some key findings from 1994-2000 include an increase in the prevalence and incidence of COPD patients on LTOT, more patients receiving mobile oxygen and starting LTOT after hospitalization. Documentation of hypoxemia improved but only about half of patients received follow-up and 20-25% still smoked. Survival rates increased over time but remained lower than other countries. The register data was not optimally utilized and direct feedback to doctors may help further improve LTOT guideline adherence.
1) Home oxygen therapy (HOT) improves survival in patients with hypoxemia, though adherence to guidelines and follow-up is only about 50% in many countries.
2) Continuous oxygen therapy (COT) given for over 15 hours daily increases survival by 2-4 years in COPD patients with low oxygen levels. Portable oxygen allows more activity but devices are still heavy.
3) International guidelines recommend COT for patients with oxygen levels below 7.3 kPa, but adherence varies, from 35-81% of eligible patients receiving treatment across different countries. Follow-up after starting COT is also inconsistent.
This document discusses home oxygen treatment. It provides an overview of the scientific evidence for indications and effects of oxygen therapy. It also reviews prevalence, devices, side effects, and practical considerations for home oxygen treatment in Denmark. A case study is presented on whether a 65-year-old woman with COPD exacerbation should start chronic oxygen therapy. Guidelines for initiating oxygen are outlined. Survival rates on oxygen are compared between countries.
Chemotherapy is the main treatment for disseminated cancers. It involves using multiple drugs in cycles to target rapidly dividing cancer cells. Common drugs include alkylating agents, antimetabolites, microtubule inhibitors, and monoclonal antibodies. Combination chemotherapy aims to maximize responses while avoiding overlapping toxicities. Doses are based on body surface area and adjusted for individual factors. Treatment intervals allow time for normal tissues to recover between cycles. Toxicities include myelosuppression, nausea/vomiting, and alopecia. Response is evaluated based on tumor shrinkage or progression.
How Smart Business Intelligence Yields Rapid Association GrowthThomas B. McClintock
After taking on the marketing challenges of ten participating organizations at MMCC ‘14, the Marketing Council’s “Doctor Is In” team has continued investigating more solutions since and has found success lies in interpreting and acting upon market data. Marketing connects people to solutions, and association marketers are uniquely positioned to make those connections across an entire vertical. But what happens when your entire vertical shifts, like healthcare or metal treatment? How can associations use Business Intelligence and Data Analytics to keep up with emerging trends and continue as a trusted resource, advisor or curator for key stakeholders? Join key association leaders who outpaced their competitors for an “Ask the Gurus” session to examine multiple best-in-class examples and distill strategies that can be scaled and applied to a wide variety of associations seeking rapid growth.
1. Yes, the patient meets the criteria for home oxygen therapy with a PO2 <7.3 kPa at rest.
2. Portable oxygen for mobile hypoxemic patients is intended to:
- Increase hours on oxygen
- Increase daily activity
3. Studies have found no effect of adding ambulatory oxygen to pulmonary rehabilitation programs. Ambulatory oxygen alone does not improve exercise tolerance long-term.
This document discusses home oxygen therapy (HOT) in various countries. It provides an overview of the types of HOT, including continuous oxygen therapy (COT), short-term oxygen therapy (STOT), and nocturnal oxygen therapy (NOT). Clinical trials show that COT improves survival in COPD patients with low oxygen levels. Guidelines for COT recommend a minimum daily usage of 15 hours and follow-up every 3-6 months. Adherence to HOT varies significantly between countries, from 60% in Denmark to rates as low as 27% in some studies. Portable oxygen improves mobility and activity levels but is underutilized in many patients.
This document summarizes findings from the Danish Oxygen Register regarding long-term oxygen therapy (LTOT) in Denmark from 1994-2000. Some key findings include:
- The prevalence and incidence of COPD patients on LTOT increased and reached a plateau around 25 and 40 per 100,000 respectively.
- There was an increase in the proportion of cancer patients, older patients, and those using mobile oxygen units starting LTOT. The percentage treated over 15 hours daily and after hospital admission also rose.
- Around 20-25% of COPD patients on LTOT were still smoking despite the therapy.
- Survival rates improved over the period, however remained lower than other countries due to higher 6-
This document discusses long-term oxygen therapy (LTOT). It provides an overview of the terminology, scientific background, equipment, indications, and quality of LTOT treatment. Specifically:
1) It defines various types of home oxygen therapy including LTOT, short-term oxygen therapy (STOT), ambulatory oxygen therapy, and oxygen used for palliation of attacks of dyspnea.
2) It reviews studies showing the effects of LTOT on survival, health outcomes, and hospitalizations for COPD patients. LTOT is shown to increase survival by 2-4 years and decrease hospitalizations by 25% for qualifying patients.
3) It discusses considerations for starting, controlling, and ensuring quality of LT
The document discusses the impact of Denmark's national oxygen register on adherence to guidelines for long-term oxygen therapy (LTOT) in COPD patients. Some key findings from 1994-2000 include an increase in the prevalence and incidence of COPD patients on LTOT, more patients receiving mobile oxygen and starting LTOT after hospitalization. Documentation of hypoxemia improved but only about half of patients received follow-up and 20-25% still smoked. Survival rates increased over time but remained lower than other countries. The register data was not optimally utilized and direct feedback to doctors may help further improve LTOT guideline adherence.
4. Rygning og iltbehandling
Effekt? Formentlig
15-24 timer/dag? Ikke hvis storryger
Sikkert? Ikke hos alle
Etiske aspekter? Seretide til rygere?
6. Formål med bærbar ilt
Iltmangel i hvile
↑timer med ilt
↑aktivitet evt. kommer på gade
Iltmangel under anstrengelse
↑fysisk formåen/mindre åndenød??
7. Akutte virkning af bærbar ilt
↓åndenød (Borg score 0.5-1.0)
↑Fysisk tolerance 5-20%
+
Vægt af udstyr
Risiko for falde i slangen
Ikke vise sig offentlig pga
generthed
-
8. Patient karakteristika
KOL: ca. 70%
Lungekræft: ca. 15%
Lungefibrose: ca. 5%
Hjertelidelse: ca. 5%
Neuromuskulær-lidelse/kyfoskoliosis: ca. 5%
Kvinder: ca. 60%
Flow: 1.4 L/min.
Alder: 72 år
9. Praktiske forhold ved LTOT
Hvordan ordineres LTOT?
Fugtet luft?
Pulssaturation versus a-punktur?
Sat.O2 ≥ 92%: stop
Sat.O2: 89-91: a-punktur
Sat.O2 ≤ 88: fortsæt
10. Prevalence of HOT in
various countries (per 100.000)
0
10
20
30
40
50
60
70
80
90
100
1987 1993 2006
DK
SE
F
N
12. Konklusioner
Iltterapi ved kronisk iltmangel forlænger
overlevelsen og mindsker symptomer
De fleste patienter starter ilt efter indlæggelse,
og omkr. Halvdelen af disse har kun behov for ilt
midlertidigt (opfølgning vigtig!).
Bærbar ilt tungt og besværligt
Generelt høj dødelighed
In 1994 the prevalence of COPD was about 27/100.000. I the following years, it increased by about 50% to 42/100.000
The incidence of COPD increased from 20 to 25/100.00 during 5 years